
Charles Dahl, MD
Cardiology & lipid disorders
Decades of cardiovascular research leadership, including PI experience in cardiovascular outcomes, acute coronary syndromes and lipid-lowering therapies.
- Provo · Experienced principal investigator
Clinical background and research leadership
Cardiology & lipid disorders
Dr. Dahl brings more than four decades of cardiology practice and longstanding cardiovascular research leadership to Boeson’s Provo site, where he has served as a principal investigator since 2024.
Clinical and research leadership: His career includes directing cardiology research at Utah Valley Regional Medical Center from 1985 to 2004, leading non-invasive cardiology and echocardiography services, and medical-director roles in clinical research at Revere Health and Aspen Clinical Research. He also has experience in medical education and cardiovascular quality review.
Research experience: His career PI work spans acute coronary syndromes, post-infarction ventricular dysfunction, cardiovascular outcomes, hypercholesterolemia and lipid-lowering therapies. His Boeson PI portfolio focuses on atherosclerotic cardiovascular disease and cardiovascular risk. This research background is complemented by clinical expertise in non-invasive cardiology and echocardiography.
Training: MD, University of Arizona Health Sciences Center; internal-medicine internship and residency, University of Utah affiliated hospitals; cardiology fellowship, University of Arizona Health Sciences Center.
Study fit: Select Dr. Dahl for deep cardiovascular trial experience, lipid expertise and experienced cardiology oversight across prevention and outcomes research.
Availability, current affiliations and protocol-specific roles are confirmed during feasibility review.
